These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Institute of Medicine's new drug safety report: implications for Canada. Cassels A. CMAJ; 2006 Dec 05; 175(12):1515-6. PubMed ID: 17146086 [No Abstract] [Full Text] [Related]
12. Adverse drug reactions, MedWatch reporting and medical student education. Lewis LD, Nierenberg DW. Pharmacoepidemiol Drug Saf; 2003 Mar 15; 12(2):93-5. PubMed ID: 12642972 [No Abstract] [Full Text] [Related]
13. [Drugs in the 3d World. Every profession has its share of responsibility]. Rosenkvist I. Sygeplejersken; 1983 Jun 01; 83(21):24-6. PubMed ID: 6555952 [No Abstract] [Full Text] [Related]
14. Most adverse drug events unreported: take these steps. Hosp Peer Rev; 2007 Oct 01; 32(10):143-5. PubMed ID: 17957885 [No Abstract] [Full Text] [Related]
15. The MedWatch Program. Love L, Couig MP. J Toxicol Clin Toxicol; 1999 Oct 01; 37(6):803-7. PubMed ID: 10584596 [No Abstract] [Full Text] [Related]
17. The growing issue of medication-related adverse events. Giaquinta D. Manag Care Interface; 2007 Oct 01; 20(10):35-6. PubMed ID: 18405205 [No Abstract] [Full Text] [Related]
18. International pharmaceutical social risk regulation: An ethical perspective. Gordon C. Acta Pharm; 2011 Mar 01; 61(1):15-23. PubMed ID: 21406340 [Abstract] [Full Text] [Related]
20. The US drug safety system: role of the pharmaceutical industry. Gibson BR, Suh R, Tilson H. Pharmacoepidemiol Drug Saf; 2008 Feb 01; 17(2):110-4. PubMed ID: 17724741 [Abstract] [Full Text] [Related] Page: [Next] [New Search]